BioSURE
Nazeing
About BioSURE
At BioSure they specialise in providing solutions. They develop, manufacture, source and distribute world class point of care rapid tests. They understand the importance of ease of use where immediate results are the primary consideration, their tests provide the highest levels of accuracy, rivalling those of standard laboratory tests. Since launching the world's first apporved HIV self test to use blood, they have become experts in this field and have unique and unrivalled knowledge of the global landscape. They passionately believe that this technology through can revolutionise testing protocols, reduce late diagnoses, provide cost effective testing solutions and engage hard to reach key populations. Ultimately budgets can be spread further through far lower delivery costs and immediate diagnosis.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: Less than $1M
- Total funding: $1.2M
- Funding stage: Early Stage Venture
- Last round: Non-Equity Assistance (Nov 2018)
- Website: hivselftest.co.uk
- Phone: [email protected]
Industries & Categories
Health Care, Manufacturing, Medical, Test and Measurement
Social Profiles
Canonical: https://fsome.com/organization/biosure-162062 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.